Supernus, Inc. is a diversified biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) diseases.
Supernus stock last closed at $29.72, up 1.78% from the previous day, and has decreased 0.37% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 1 percentage points. Supernus stock is currently +14.66% from its 52-week low of $25.92, and -30.58% from its 52-week high of $42.81.
At the moment, there are 118.04M SUPN shares outstanding. The market capitalization of SUPN is $3.51B. In the last 24 hours, 2.07M SUPN shares were traded.
How to Buy Supernus Stock
Wondering how to invest in Supernus stock? Here's how.
Figure out where to buy Supernus stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you choose where to buy Supernus stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Put funds into your brokerage account: Choose your payment method and add your information.
Research Supernus stock: The Supernus ticker symbol is SUPN. Is Supernus stock a good investment? Should you buy shares of SUPN? How do SUPN's underlying business fundamentals look? Do top analysts think Supernus is a good buy? Why has SUPN's stock price moved recently? (Hint: Our stock market research website can help you evaluate if SUPN is a good stock to buy).
Make your SUPN buy order: Decide if you will purchase SUPN shares at the current market price or use a limit order to buy SUPN shares at a given price.
Get the latest news on your investment in SUPN: Create a watchlist to keep tabs on your investment in Supernus shares.
Step 1: Figure out where to buy Supernus stock
You will need a brokerage account to access the NASDAQ market and buy SUPN stock.
A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you can invest in SUPN stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Supernus stock
After you have figured out the best place to buy Supernus stock, it's critical to analyze their stock prior to investing, so you can comprehend the risk as well as the upside.
Overview of key SUPN info
SUPN Price
$29.72
1w %
13.61%
1y %
-0.37%
5y %
N/A
P/E
8.03x
P/B
-58.47x
P/S
2.55x
PEG
0.53x
Revenue
$1.37B
Earnings
$450.00M
Fore. Rev. Growth
3.56%
Fore. Earn. Growth
15.08%
Market Cap
$3.51B
Next Earnings
N/A
Next Dividend
N/A
SUPN Fundamentals
WallStreetZen was built to help average investors do better fundamental analysis in minutes instead of hours.
Last year, SUPN earnings were $450.00M. Over the past one years, SUPN's earnings have grown by 259.22% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of -4.94%.
Last year, SUPN revenue was $1.37B. During the past three year, SUPN's revenue has increased by 68.3% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 8%.
Supernus pays a dividend of 27.36%, compared to the Drug Manufacturers - Specialty & Generic industry's average dividend yield of 7.25%. If you owned $1,000 of SUPN stock, you would have received $273.55 in the past year.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your SUPN buy order
There are two main order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are usually fine.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a given dollar amount, use a limit order.
Press the Open Trade button and eToro will execute the order.
If you require additional help investing in stocks on eToro, click the helpful video below:
As of Nov 13, 2026, it costs $29.72 to buy one share of Supernus stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.336 shares of SUPN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.